U.K., Aug. 5 -- ANA Therapeutics is a Silicon Valley, California-based biotech company developing a coronavirus vaccine.
Founded earlier this year, the company has announced that the US Food and Drug Administration (FDA) has cleared its investigation into using niclosamide capsules as a potential COVID-19 treatment, allowing for human trials.
The company said it would perform the trial with 400 COVID-19 afflicted patients at 10 centres across the US. Specifically, these will be places experiencing a current surge such as Florida and Texas - with the aim being to entol the first patient in August.
The trial will assess niclosamide's safety and its potential to alleviate symptoms. Niclosamide is a pre-existing drug chiefly used to treat t...